Radiopharmaceuticals Market to Grow to US$ 4,000 MN by 2026-End

Information about Radiopharmaceuticals Market to Grow to US$ 4,000 MN by 2026-End

Published on February 12, 2019

Author: amirshaikh7

Source: authorstream.com

Content

slide 1: Healthcare Pharmaceuticals Medical Devices February 2017 ©2015 Future Market Insights All Rights Reserved Report Id : REP-GB-1992 Status : Publish Category : Healthcare Pharmaceuticals Medical Devices slide 2: About Future Market Insights ©2015 Future Market Insights All Rights Reserved Future Market Insights FMI is a premier provider of syndicated research reports custom research reports and consulting services. We deliver a complete packaged solution which combines current market intelligence statistical anecdotes technology inputs valuable growth insights aerial view of the competitive framework and future market trends. We provide research services at a global as well as regional level key regions include GCC ASEAN and BRIC. Our offerings cover a broad spectrum of industries including Chemicals Materials Energy Technology Healthcare and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London U.K. with a state-of-the-art delivery center located in Pune India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Subscription Information  Customized Research  Syndicated Research  Investment Research  Social Media Research Sector Coverage  Automotive and Transportation  Electronics Semiconductor and ICT  Retail and Consumer Products  Industrial Automation and Equipment  Chemicals Materials  Food and Beverages  Services and Utilities  Energy Mining Oil and Gas For detailed subscription information please contact Hari. T Sr. Manager - Global Business Development T: +44 0 20 7692 8790 | D: +44 20 3287 4268 Email: hari.tfuturemarketinsights.com Customized Research Syndicated Research Investment Research Social Media Research 2 slide 3: Research Methodology 1/2 Systematic Research Approach In-depth secondary research is used to ascertain overall market size top industry players top products industry associations etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players manufacturers distributors retailers and industry experts PMR conducts interviews with industry experts industry players distributors and retailers Data is validated by triangulation method wherein secondary primary and PMR analysis contribute to the final data Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format PDF Data Collection Data Filter Analysis Research Intelligence Actionable Insights Business Solution A C B Primary Research Company Analysis Desk Research  Identifying key opinion leaders  Questionnaire design  In-depth interviews  Coverage across value chain  Market participants  Key strengths  Product portfolio  Mapping as per value chain  Key focus segments  Key industry experts  Channel study  Developments  Market dynamics  Products  Conclusions SOLUTION Primary Research  Linkedin  Zoominfo  Salesforce  Avention  Factiva  GBI  Genios  Meltwater  Company websites  Company annual reports  White papers  Financial reports ©2015 Future Market Insights All Rights Reserved Secondary Research Paid Publications Insights Market profiling Formulating discussion guide Developing list of respondents Data analysis Data validation Data collection 1 2 3 4 5 6 7 includes sources of databases 3 slide 4: Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour cells and tissues. Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals. In a recent report published by Future Market Insights the global radiopharmaceuticals revenues in 2016 reached an estimated US 4800 million value and are anticipated to close in on US 8500 million by the end of 2026. In terms of revenue the global radiopharmaceuticals market is projected to soar steadily at 5.9 CAGR. Future Market Insights predicts that shorter half-life of radiopharmaceuticals and lack of specified guidelines for their use in commercial-scale drug production will restrict the market from growing at higher rate. In the years to come ageing research reactors from all corners of the world will be closed which will significantly bring down global production of radiopharmaceuticals. With respect to sourcing these radiopharmaceuticals the report predicts that nuclear reactors have accounted for more than 60 of global market revenues till date. Radiopharmaceuticals Market Analysis ©2015 Future Market Insights All Rights Reserved 4 slide 5: Shutting down these reactors however has propelled the installation of cyclotrons which are also a feasible source for radioisotopes. Hence sales of radiopharmaceuticals derived from cyclotrons will continue to increase amassing more than US 6500 million by the end of 2026. Request Sample Report https://www.futuremarketinsights.com/reports/sample/rep-gb-1992 Surging Demand for Technetium-99 Radioisotope Production of radiopharmaceuticals can be classified into several key radioisotopes the prominent ones include fluorine-18 leutetium-177 gallium-68 gallium-67 and technetium-99. In 2016 sales of radiopharmaceuticals constituting technetium-99 amassed revenues worth over US 2200 million globally. By the end of 2026 fluorine-18 radioisotope will continue to account for 16 of global radiopharmaceuticals revenues. On the other hand global radiopharmaceutical revenues accounted by leutetium-177 gallium-68 and gallium-67 respectively will soar at more than 6 CAGR through 2026. Radiopharmaceuticals Market Analysis ©2015 Future Market Insights All Rights Reserved 5 slide 6: North America – Dominant Region for Sales of Radiopharmaceuticals Access to advanced medical facilities highly-trained professionals and lucrative healthcare expenditure adds up to make North America the most dominant region in global radiopharmaceuticals market. North Ame r i c a’ s radiopharmaceuticals revenues will grow at more than 6 CAGR accounting for nearly 50 of global revenues by the end of 2026. Companies such as Positron Corporation GE Healthcare Mallinckrodt plc Lantheus Holdings Inc. and Nordion Inc. are observed to be leading players in global radiopharmaceuticals market and are all based across North America. Siemens Healthineers is slated to remain the most dominant company in the global radiopharmaceuticals market accounting for over 40 of global revenues. Due to participation of Siemens and companies such as Advanced Accelerator Applications France Bayer AG Germany IBA Radiopharma Solutions Belgium and Eckert Zeigler Germany Western Eu r ope’ s radiopharmaceuticals market is also expected to expand progressively and close in on US 1600 million valuation by the end of 2026. Radiopharmaceuticals – Scope for Application End-use Favourable growth opportunities for radiopharmaceutical manufacturers from around the world are sited in therapeutic applications such as oncology cardiology neuroendocrinology and neurology among others. Radiopharmaceuticals Market Analysis ©2015 Future Market Insights All Rights Reserved 6 slide 7: In 2017 and beyond consumption of radiopharmaceuticals for oncological procedures will gain traction registering revenue growth at 6 CAGR. On the other hand radiopharmaceuticals consumed by neurological studies treatment procedures will surge at the highest rate surpassing US 700 million valuation by 2026-end. Request to View TOC https://www.futuremarketinsights.com/askus/rep-gb-1992 Another key insight offered in the report suggests that radiopharmaceuticals used by diagnostic imaging centres will increase over the forecast period. Nevertheless every second radiopharmaceutical product manufactured in the world will be used by hospitals. Radiopharmaceuticals Market Analysis ©2015 Future Market Insights All Rights Reserved 7 Click here to Order a free sample slide 8: ©2015 Future Market Insights All Rights Reserved Future Market Insights Global Consulting Private Limited FMI Thank You To know more about us please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: salesfuturemarketinsights.com For media queries contact the press office at pressfuturemarketinsights.com For other queries contact: Hari. T Sr. Manager - Global Business Development Future Market Insights: 3rd Floor 207 Regent Street London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.tfuturemarketinsights.com 8

Related presentations


Other presentations created by amirshaikh7